SHARES of YSP Southeast Asia Bhd have gained momentum in recent weeks amid expectations that the generic drug manufacturer could see strong growth this year.
This comes following the company’s encouraging performance year to date amid improving prospects in the domestic market.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
